The impact of hospitalization on mortality in patients with connective tissue disease-associated interstitial lung disease: a medical records review study

Anna Korogodina,Navneet Kaur,Xianhong Xie,Adhya Mehta,Krystal L. Cleven,Bibi Ayesha,Anand Kumthekar
DOI: https://doi.org/10.1186/s42358-023-00343-x
2024-01-02
Advances in Rheumatology
Abstract:Abstract Background Interstitial lung disease (ILD) remains one of the most important causes of morbidity and mortality in patients with Connective Tissue Diseases (CTD). This study evaluated the impact of hospitalization on mortality in an ethnically and racially diverse cohort of CTD-ILD patients. Methods We conducted a medical records review study at Montefiore Medical Center, Bronx, NY. We included 96 patients and collected data on demographic characteristics, reasons for hospitalization, length of stay, immunosuppressant therapy use, and mortality. We stratified our patients into two cohorts: hospitalized and non-hospitalized. The hospitalized cohort was further subdivided into cardiopulmonary and non-cardiopulmonary admissions. Two-sample tests or Wilcoxon’s rank sum tests for continuous variables and Chi-square or Fisher’s exact tests for categorical variables were used for analyses as deemed appropriate. Results We identified 213 patients with CTD-ILD. Out of them, 96 patients met the study’s inclusion criteria. The majority of patients were females (79%), and self-identified as Hispanic (54%) and Black (40%). The most common CTDs were rheumatoid arthritis (RA) (29%), inflammatory myositis (22%), and systemic sclerosis (15%). The majority (76%) of patients required at least one hospitalization. In the non-hospitalized group, no deaths were observed, however we noted significant increase of mortality risk in hospitalized group ( p = 0.02). We also observed that prolonged hospital stay (> 7 days) as well as older age and male sex were associated with increased mortality. Conclusions Prolonged (> 7 days) hospital stay and hospitalization for cardiopulmonary causes, as well as older age and male sex were associated with an increased mortality risk in our cohort of CTD-ILD patients.
rheumatology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the impact of hospitalization on the mortality rate of patients with connective tissue disease - related interstitial lung disease (CTD - ILD). Specifically, the study aims to explore whether hospitalization (especially hospitalization due to cardiac or pulmonary reasons) is associated with an increased risk of death in patients with CTD - ILD through a retrospective analysis of a patient cohort with significant racial and ethnic diversity. ### Research Background - **Connective Tissue Disease (CTD)** is a group of autoimmune diseases, including systemic sclerosis (SSc), polymyositis/dermatomyositis (PM/DM), rheumatoid arthritis (RA), Sjögren's syndrome (SS), vasculitis, mixed connective tissue disease (MCTD) and systemic lupus erythematosus (SLE). - **Interstitial Lung Disease (ILD)** is one of the most common pulmonary manifestations of CTD, resulting in significant morbidity and mortality. - **CTD - ILD** refers to the inflammation and fibrosis of the lung parenchyma associated with various autoimmune diseases. ### Research Objectives - **To evaluate the impact of hospitalization on the mortality rate of patients with CTD - ILD**. - **To identify high - risk patients** for early intervention, adjustment of treatment regimens and improvement of prognosis. ### Main Findings - **The mortality rate of hospitalized patients is significantly higher than that of non - hospitalized patients**. - Patients with **long - term hospitalization (more than 7 days)** and **hospitalization due to cardiac or pulmonary reasons** have a higher risk of death. - **Older** and **male** patients also have a higher risk of death. ### Conclusions - Hospitalization, especially hospitalization due to cardiac or pulmonary reasons and with a length of stay exceeding 7 days, is an adverse prognostic factor for death in patients with CTD - ILD. - These findings are helpful for identifying high - risk patients and conducting close monitoring after discharge. - Further efforts are needed to promote the multidisciplinary care model to identify and manage high - risk patients with CTD - ILD.